+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Smallpox Drug"

Smallpox - Pipeline Insight, 2024 - Product Thumbnail Image

Smallpox - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
Smallpox - Epidemiology Forecast to 2032 - Product Thumbnail Image

Smallpox - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Global Smallpox Treatment Market 2022-2026 - Product Thumbnail Image

Global Smallpox Treatment Market 2022-2026

  • Report
  • April 2022
  • 120 Pages
  • Global
From
Smallpox - Pipeline Review, H2 2020 - Product Thumbnail Image

Smallpox - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 85 Pages
  • Global
From
Smallpox (Infectious Disease) - Drugs in Development, 2021 - Product Thumbnail Image

Smallpox (Infectious Disease) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Smallpox is a highly contagious and potentially fatal infectious disease caused by the variola virus. Smallpox was declared eradicated in 1980, however, the threat of a bioterrorist attack using the virus has led to the development of drugs to treat the disease. The smallpox drug market is a subset of the infectious diseases drugs market. It includes drugs used to treat smallpox, as well as vaccines to prevent it. Vaccines are the primary form of prevention, but antiviral drugs are also used to treat the disease. These drugs work by targeting the virus and preventing it from replicating. The smallpox drug market is highly competitive, with several companies developing drugs and vaccines. These include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Johnson & Johnson. Show Less Read more